Both p62/SQSTM1-HDAC6-dependent autophagy and the aggresome pathway mediate CDK1 degradation in human breast cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-10506-8.pdf
Reference38 articles.
1. Santamaria, D. et al. Cdk1 is sufficient to drive the mammalian cell cycle. Nature 448, 811–815, doi: 10.1038/nature06046 (2007).
2. Liu, P., Kao, T. P. & Huang, H. CDK1 promotes cell proliferation and survival via phosphorylation and inhibition of FOXO1 transcription factor. Oncogene 27, 4733–4744, doi: 10.1038/onc.2008.104 (2008).
3. Schwermer, M. et al. Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors. Oncotarget 6, 15425–15435, doi: 10.18632/oncotarget.3908 (2015).
4. Zhang, C. et al. Loss of cytoplasmic CDK1 predicts poor survival in human lung cancer and confers chemotherapeutic resistance. PloS one 6, e23849, doi: 10.1371/journal.pone.0023849 (2011).
5. Malumbres, M. & Barbacid, M. Mammalian cyclin-dependent kinases. Trends in biochemical sciences 30, 630–641, doi: 10.1016/j.tibs.2005.09.005 (2005).
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HDAC6 mediates tumorigenesis during mitosis and the development of targeted deactivating agents;Bioorganic Chemistry;2024-09
2. Kinesin KIF3A regulates meiotic progression and spindle assembly in oocyte meiosis;Cellular and Molecular Life Sciences;2024-04-08
3. Specific proteolysis mediated by a p97-directed proteolysis-targeting chimera (PROTAC);2024-03-09
4. Identification of CDK1, PBK, and CHEK1 as an Oncogenic Signature in Glioblastoma: A Bioinformatics Approach to Repurpose Dapagliflozin as a Therapeutic Agent;International Journal of Molecular Sciences;2023-11-16
5. In Silico Mixed Ligand/Structure-Based Design of New CDK-1/PARP-1 Dual Inhibitors as Anti-Breast Cancer Agents;International Journal of Molecular Sciences;2023-09-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3